| |
Diagnostic testing
|
Presumptive treatment
|
Recommended febrile case managemente
|
|---|
|
aOR
|
95% CI
|
aOR
|
95% CI
|
aOR
|
95% CI
|
|---|
|
District-level
|
|
EVD-affected district
|
–
|
–
|
0.07*
|
0.01–0.73
|
–
|
–
|
|
Facility/health worker-level
|
|
EVD case report
|
0.04*
|
0.01–0.18
|
982*
|
24.9–999
|
–
|
–
|
|
Glove availabilitya
|
5.38*
|
1.96–14.7
|
0.21*
|
0.06–0.74
|
–
|
–
|
|
Adequate PPE availabilityb
|
–
|
–
|
4.75
|
0.83–27.1
|
192*
|
12.1–> 999
|
|
Malaria trainingc
|
0.21*
|
0.05–0.88
|
12.2*
|
1.20–124
|
2.97
|
0.91–9.73
|
|
EVD trainingd
|
–
|
–
|
–
|
–
|
0.25
|
0.05–1.14
|
|
Received PPE training
|
4.97*
|
1.78–13.8
|
–
|
–
| | |
|
Anti-malarial availabilitya
|
10.4*
|
4.29–25.1
|
0.06*
|
0.01–0.31
|
0.08*
|
0.01–0.69
|
|
RDT availabilitya
|
–
|
–
| | |
19.3
|
0.81–462
|
|
Facility
|
|
Health centre
|
3.55*
|
1.03–12.2
|
0.09*
|
0.02–0.36
|
0.04*
|
0.01–0.37
|
|
Hospital
|
–
|
–
|
< 0.01*
|
< 0.01–0.02
|
0.02*
|
< 0.01–0.36
|
|
Health post (ref)
|
1
|
–
|
–
|
–
|
–
|
–
|
|
Patient-level
|
|
Age ≥ 5 years old
|
–
|
–
|
0.54*
|
0.36–0.79
|
0.43*
|
0.21–0.88
|
- RDT rapid diagnostic test, PPE personal protective equipment, EVD Ebola virus disease, 95% CI confidence interval
- * Significant at p < 0.05 Note: results are weighted
- – Signifies variable that was included in full model but fell out of model during backwards model selection using stay criterion of α < 0.10
- aAvailability: Availability of examination gloves defined as ≥ 100% of average monthly glove consumption available at time of survey visit
- bReported availability of gloves, apron, boots, helmet, and face screen at time of survey visit
- cHealth worker reported having received training on malaria case management in context of EVD epidemic in previous 6 months
- dHealth worker reported having received training on EVD case management and identification in context of EVD epidemic in previous 6 months
- eRecommended febrile case management defined as diagnostic test for febrile patients in presence of adequate PPE and treatment according to result or presumptive anti-malarial treatment for febrile patients in absence of adequate PPE
